Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
NATCO Pharma Q3 profit plunges around 38%, stock hits 52-week low
NATCO Pharma Ltd reported a 37.75 per cent decline in consolidated net profit to ₹132.4 crore for Q3 FY2025, down from ₹212.7 crore in the
Natco Pharma Q3 Results: Net profit declines 38% to ₹132.4 crore, dividend declared
Natco Pharma Q3 Results: NATCO Pharma Ltd reported a sharp decline of 37.75 percent in consolidated net profit for the December quarter, primarily impacted by
Natco Pharma’s Q3 net down 37% to ₹132 crore
Natco Pharma’s consolidated net profit declined 37 per cent to ₹132 crore in the third quarter ended December 31, 2024, as against ₹212 crore in
Nifty Pharma drops over 2%, 19 index stocks tumble up to 7%. What triggered this fall?
Stock Market Today: Indian pharma stocks faced significant selling pressure in today’s session, February 10, driven by weak earnings in select companies and fears that